Literature DB >> 25676565

Role of fish oil in human health and possible mechanism to reduce the inflammation.

Mohammed S Ellulu1, Huzwah Khaza'ai, Yehia Abed, Asmah Rahmat, Patimah Ismail, Yazan Ranneh.   

Abstract

The roles of Omega-3 FAs are inflammation antagonists, while Omega-6 FAs are precursors for inflammation. The plant form of Omega-3 FAs is the short-chain α-linolenic acid, and the marine forms are the long-chain fatty acids: docosahexaenoic acid and eicosapentaenoic acid. Omega-3 FAs have unlimited usages, and they are considered as omnipotent since they may benefit heart health, improve brain function, reduce cancer risks and improve people's moods. Omega-3 FAs also have several important biological effects on a range of cellular functions that may decrease the onset of heart diseases and reduce mortality among patients with coronary heart disease, possibly by stabilizing the heart's rhythm and by reducing blood clotting. Some review studies have described the beneficial roles of Omega-3 FAs in cardiovascular diseases (CVDs), cancer, diabetes, and other conditions, including inflammation. Studies of the effect of Omega-3 FAs gathered from studies in diseased and healthy population. CVDs including atherosclerosis, coronary heart diseases, hypertension, and metabolic syndrome were the major fields of investigation. In studies of obesity, as the central obesity increased, the level of adipocyte synthesis of pro-inflammatory cytokines like tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) were increased and the level of anti-inflammatory adiponectin was decreased indicating a state of inflammation. The level of C reactive protein (CRP) synthesized from hepatocyte is increased by the influence of IL-6. CRP can be considered as a marker of systemic inflammation associated with increased risks of CVDs. In molecular studies, Omega-3 FAs have direct effects on reducing the inflammatory state by reducing IL-6, TNF-α, CRP and many other factors. While the appropriate dosage along with the administrative duration is not known, the scientific evidence-based recommendations for daily intake are not modified.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25676565     DOI: 10.1007/s10787-015-0228-1

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  80 in total

1.  Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial.

Authors:  Janice K Kiecolt-Glaser; Martha A Belury; Rebecca Andridge; William B Malarkey; Beom Seuk Hwang; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2012-05-26       Impact factor: 7.217

2.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

Review 3.  The autocrine and paracrine roles of adipokines.

Authors:  Kalypso Karastergiou; Vidya Mohamed-Ali
Journal:  Mol Cell Endocrinol       Date:  2009-12-03       Impact factor: 4.102

4.  Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome.

Authors:  Hilary M F Tulk; Lindsay E Robinson
Journal:  Metabolism       Date:  2009-07-21       Impact factor: 8.694

Review 5.  Omega-3 fatty acids in health and disease and in growth and development.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

Review 6.  Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Authors:  Paul Trayhurn; I Stuart Wood
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

Review 7.  Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.

Authors:  Hiroyuki Seki; Yukako Tani; Makoto Arita
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-25       Impact factor: 3.072

8.  Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.

Authors:  Songwen Zhang; Qiangyuan Liu; Juan Wang; Douglas C Harnish
Journal:  Biochem Biophys Res Commun       Date:  2008-12-30       Impact factor: 3.575

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.

Authors:  Florian Blaschke; Yasunori Takata; Evren Caglayan; Alan Collins; Peter Tontonoz; Willa A Hsueh; Rajendra K Tangirala
Journal:  Circ Res       Date:  2006-11-16       Impact factor: 17.367

View more
  19 in total

1.  Factors Associated with Multiple Biomarkers of Systemic Inflammation.

Authors:  Sandi L Navarro; Elizabeth D Kantor; Xiaoling Song; Ginger L Milne; Johanna W Lampe; Mario Kratz; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-11       Impact factor: 4.254

Review 2.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

3.  A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression.

Authors:  Vilma Gabbay; Rachel D Freed; Carmen M Alonso; Stefanie Senger; Jill Stadterman; Beth A Davison; Rachel G Klein
Journal:  J Clin Psychiatry       Date:  2018-06-26       Impact factor: 4.384

Review 4.  Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives.

Authors:  Mimi Chung; Erin Bartholomew; Samuel Yeroushalmi; Marwa Hakimi; Tina Bhutani; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2022-06-22

5.  Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats.

Authors:  Abhijit Ghadge; Abhay Harsulkar; Manjiri Karandikar; Vijaya Pandit; Aniket Kuvalekar
Journal:  Genes Nutr       Date:  2016-03-17       Impact factor: 5.523

6.  Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial.

Authors:  Gitte S Jensen; Miki Lenninger; Michael P Ero; Kathleen F Benson
Journal:  Integr Blood Press Control       Date:  2016-10-13

Review 7.  Alcoholic Liver Disease: Update on the Role of Dietary Fat.

Authors:  Irina A Kirpich; Matthew E Miller; Matthew C Cave; Swati Joshi-Barve; Craig J McClain
Journal:  Biomolecules       Date:  2016-01-06

8.  Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resilience in a marine teleostean fish fed vegetable diets.

Authors:  María Carla Piazzon; Josep Alvar Calduch-Giner; Belén Fouz; Itziar Estensoro; Paula Simó-Mirabet; Mónica Puyalto; Vasileios Karalazos; Oswaldo Palenzuela; Ariadna Sitjà-Bobadilla; Jaume Pérez-Sánchez
Journal:  Microbiome       Date:  2017-12-28       Impact factor: 14.650

9.  Can you hear me now? The quest for better guidance on omega-3 fatty acid consumption to combat hearing loss.

Authors:  Ana C Fiorini; Orozimbo A Costa; Fulvio A Scorza
Journal:  Clinics (Sao Paulo)       Date:  2016-08       Impact factor: 2.365

10.  N-3 Polyunsaturated Fatty Acids Decrease the Protein Expression of Soluble Epoxide Hydrolase via Oxidative Stress-Induced P38 Kinase in Rat Endothelial Cells.

Authors:  Takashi Okada; Katsutaro Morino; Fumiyuki Nakagawa; Masashi Tawa; Keiko Kondo; Osamu Sekine; Takeshi Imamura; Tomio Okamura; Satoshi Ugi; Hiroshi Maegawa
Journal:  Nutrients       Date:  2017-06-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.